Article
Cyclosporin A delays the terminal disease stage in <i>Tfam</i> KO mice without improving mitochondrial energy production
2022-10-18
Abstract excerpt
<h4> A bstract </h4> Mitochondrial myopathies are rare genetic disorders characterized by muscle weakness and exercise intolerance. Currently, no effective treatment exists for these myopathies. Interestingly, the pharmacological cyclophilin inhibitor cyclosporine A (CsA) extended lifespan and prevented loss of force and mitochondrial Ca 2+ overload in muscle fibers in the skeletal muscle-specific Tfam knocko...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 477147e8-5b63-5a85-b9ec-cb207250b47a
- DOI
- 10.1101/2022.10.14.511701
